| UniProt ID | TBAL3_HUMAN | |
|---|---|---|
| UniProt AC | A6NHL2 | |
| Protein Name | Tubulin alpha chain-like 3 | |
| Gene Name | TUBAL3 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 446 | |
| Subcellular Localization | Cytoplasm, cytoskeleton. | |
| Protein Description | Tubulin is the major constituent of microtubules. It binds two moles of GTP, one at an exchangeable site on the beta chain and one at a non-exchangeable site on the alpha chain (By similarity).. | |
| Protein Sequence | MRECLSIHIGQAGIQIGDACWELYCLEHGIQPNGVVLDTQQDQLENAKMEHTNASFDTFFCETRAGKHVPRALFVDLEPTVIDGIRTGQHRSLFHPEQLLSGKEDAANNYARGRYSVGSEVIDLVLERTRKLAEQCGGLQGFLIFRSFGGGTGSGFTSLLMERLTGEYSRKTKLEFSVYPAPRISTAVVEPYNSVLTTHSTTEHTDCTFMVDNEAVYDICHRKLGVECPSHASINRLVVQVVSSITASLRFEGPLNVDLIEFQTNLVPYPRIHFPMTAFAPIVSADKAYHEQFSVSDITTACFESSNQLVKCDPRLGKYMACCLLYRGDVVPKEVNAAIAATKSRHSVQFVDWCPTGFKVGINNRPPTVMPGGDLAKVHRSICMLSNTTAIVEAWARLDHKFDLMYAKRAFLHWYLREGMEEAEFLEAREDLAALERDYEEVAQSF | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 92 | Phosphorylation | IRTGQHRSLFHPEQL CCCCCCHHCCCHHHH | 33.01 | 20068231 | |
| 101 | Phosphorylation | FHPEQLLSGKEDAAN CCHHHHHCCCHHHHH | 57.31 | 20068231 | |
| 103 | Methylation | PEQLLSGKEDAANNY HHHHHCCCHHHHHHH | 49.39 | - | |
| 103 | Sumoylation | PEQLLSGKEDAANNY HHHHHCCCHHHHHHH | 49.39 | - | |
| 110 | Phosphorylation | KEDAANNYARGRYSV CHHHHHHHHCCCCCC | 9.48 | 28152594 | |
| 115 | Phosphorylation | NNYARGRYSVGSEVI HHHHCCCCCCHHHHH | 15.55 | - | |
| 161 | Sulfoxidation | SGFTSLLMERLTGEY CHHHHHHHHHHHCCC | 3.23 | 21406390 | |
| 172 | Phosphorylation | TGEYSRKTKLEFSVY HCCCCCCCEEEEEEE | 39.49 | - | |
| 192 | Phosphorylation | STAVVEPYNSVLTTH EEEEEECCCCEEECC | 13.43 | 22468782 | |
| 197 | Phosphorylation | EPYNSVLTTHSTTEH ECCCCEEECCCCCCC | 21.95 | 22468782 | |
| 208 | Phosphorylation | TTEHTDCTFMVDNEA CCCCCCCEEEECCHH | 19.99 | 22468782 | |
| 243 | Phosphorylation | RLVVQVVSSITASLR HHHHHHHHHHHHEEC | 19.71 | 21406692 | |
| 244 | Phosphorylation | LVVQVVSSITASLRF HHHHHHHHHHHEECC | 16.61 | 21406692 | |
| 246 | Phosphorylation | VQVVSSITASLRFEG HHHHHHHHHEECCCC | 16.49 | 21406692 | |
| 248 | Phosphorylation | VVSSITASLRFEGPL HHHHHHHEECCCCCC | 16.07 | 21406692 | |
| 269 | Phosphorylation | FQTNLVPYPRIHFPM EECCCCCCCCCCCCC | 9.54 | 22817900 | |
| 278 | Ubiquitination | RIHFPMTAFAPIVSA CCCCCCCEECCCCCC | 7.73 | 23503661 | |
| 278 (in isoform 2) | Ubiquitination | - | 7.73 | - | |
| 316 | Phosphorylation | LVKCDPRLGKYMACC EEECCHHHHHHCHHH | 9.38 | 32142685 | |
| 318 | Acetylation | KCDPRLGKYMACCLL ECCHHHHHHCHHHHH | 36.12 | 26051181 | |
| 318 | Ubiquitination | KCDPRLGKYMACCLL ECCHHHHHHCHHHHH | 36.12 | 23503661 | |
| 319 | Phosphorylation | CDPRLGKYMACCLLY CCHHHHHHCHHHHHC | 6.53 | 28152594 | |
| 320 | Sulfoxidation | DPRLGKYMACCLLYR CHHHHHHCHHHHHCC | 2.34 | 30846556 | |
| 326 | Phosphorylation | YMACCLLYRGDVVPK HCHHHHHCCCCCCCH | 10.29 | 22817900 | |
| 342 | Phosphorylation | VNAAIAATKSRHSVQ HHHHHHHCCCCCEEE | 22.11 | 17924679 | |
| 356 | Phosphorylation | QFVDWCPTGFKVGIN EEEEECCCCCEEECC | 52.71 | 32142685 | |
| 361 (in isoform 2) | Ubiquitination | - | 19.93 | 21890473 | |
| 361 | Ubiquitination | CPTGFKVGINNRPPT CCCCCEEECCCCCCC | 19.93 | 32142685 | |
| 368 (in isoform 2) | Ubiquitination | - | 31.92 | 21890473 | |
| 368 | Ubiquitination | GINNRPPTVMPGGDL ECCCCCCCCCCCCHH | 31.92 | 21963094 | |
| 401 | Sumoylation | AWARLDHKFDLMYAK HHHHCCCHHHHHHHH | 39.99 | - | |
| 401 | Ubiquitination | AWARLDHKFDLMYAK HHHHCCCHHHHHHHH | 39.99 | 32142685 | |
| 401 (in isoform 1) | Ubiquitination | - | 39.99 | 21890473 | |
| 401 | Sumoylation | AWARLDHKFDLMYAK HHHHCCCHHHHHHHH | 39.99 | - | |
| 401 | Acetylation | AWARLDHKFDLMYAK HHHHCCCHHHHHHHH | 39.99 | 155461 | |
| 405 | Sulfoxidation | LDHKFDLMYAKRAFL CCCHHHHHHHHHHHH | 3.09 | 21406390 | |
| 406 | Phosphorylation | DHKFDLMYAKRAFLH CCHHHHHHHHHHHHH | 19.10 | 28674151 | |
| 408 | Sumoylation | KFDLMYAKRAFLHWY HHHHHHHHHHHHHHH | 27.11 | - | |
| 408 | Ubiquitination | KFDLMYAKRAFLHWY HHHHHHHHHHHHHHH | 27.11 | 21906983 | |
| 408 | Sumoylation | KFDLMYAKRAFLHWY HHHHHHHHHHHHHHH | 27.11 | - | |
| 408 | Acetylation | KFDLMYAKRAFLHWY HHHHHHHHHHHHHHH | 27.11 | 19608861 | |
| 408 (in isoform 1) | Ubiquitination | - | 27.11 | 21890473 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of TBAL3_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of TBAL3_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of TBAL3_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| TCPH_HUMAN | CCT7 | physical | 26186194 | |
| TCPG_HUMAN | CCT3 | physical | 26186194 | |
| TCPW_HUMAN | CCT6B | physical | 26186194 | |
| TCPZ_HUMAN | CCT6A | physical | 26186194 | |
| TCPA_HUMAN | TCP1 | physical | 26186194 | |
| TCPB_HUMAN | CCT2 | physical | 26186194 | |
| RIC8B_HUMAN | RIC8B | physical | 26186194 | |
| TCPB_HUMAN | CCT2 | physical | 28514442 | |
| TCPG_HUMAN | CCT3 | physical | 28514442 | |
| TCPH_HUMAN | CCT7 | physical | 28514442 | |
| TCPZ_HUMAN | CCT6A | physical | 28514442 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Acetylation | |
| Reference | PubMed |
| "Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-401 AND LYS-408, AND MASSSPECTROMETRY. | |
| Phosphorylation | |
| Reference | PubMed |
| "Improved titanium dioxide enrichment of phosphopeptides from HeLacells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra."; Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.; J. Proteome Res. 6:4150-4162(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-342, AND MASSSPECTROMETRY. | |